Cancer
- Cancer PHGKB -
What's New
Last Posted: Sep 26, 2019
- Appraising the causal relevance of DNA methylation for risk of lung cancer.
Battram Thomas et al. International journal of epidemiology 2019 Sep - Better Genetic Testing Guidelines Needed to Identify More At-Risk Patients
Managed Care Executive, September 25, 2019 - Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
H Zhang et al, BiorXIV, September 2019 - 'Revolutionary' new class of cancer drugs approved
J Gallagher, BBC News, September 23, 2019 - Context is everything: aneuploidy in cancer
UB David, Nat Rev Genetics, September 23, 2019 - Is Everyone Doing Chemo Without Me?
J Wana, NY Times, September 24, 2019 - Will AI help universalize health care
S Balsari, BMJ Blog, September 23, 2019 - Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non–Small Cell Lung Cancer
Y Chen et al, JAMA Network Open, September 20, 2019 - Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network
AN Burnett-Hartmann et al, JCO Clin Cancer Informatics, September 2019 - Cancer: more genetic BRCA testing for men
M Marabelli et al, Nature, September 17, 2019 - Overall Mortality After Diagnosis of Breast Cancer in Men vs Women.
Wang Fei et al. JAMA oncology 2019 Sep - Implementation science and genomic medicine in action: A case study
M Clyne et al, CDC Blog, September 18, 2019 - Should You Get Genetic Testing for Cancer Risk?
American Cancer Society, September 18, 2019 - Cancer Patients Have Limited Understanding of Genomic Test Results
Health Analytics, September 2019 - Men at High Risk for Breast Cancer May Benefit From Screening
R Nelson, Medscape, September 17, 2019
.png)
No hay comentarios:
Publicar un comentario